Juvenile nasopharyngeal angiofibroma: A clinical case report and a literature review

John Esteban Verdugo Parra 1, *, Kevin Fabricio Orellana Barros 1, Hugo Xavier Guamán Roldan 2 and Janneth Alexandra Villavicencio Benavides 3

1 Students of the Faculty of Dentistry at the University of Cuenca, Ecuador.
2 Oral and maxillofacial surgeons from the National Autonomous University of Mexico, Mexico; Lecturer at the Faculty of Dentistry at the University of Cuenca, Ecuador.
3 Specialist doctor in otorhinolaryngology at the Portoviejo Specialty Hospital, Ecuador.
Case Study
World Journal of Advanced Research and Reviews, 2024, 22(03), 1693–1700
Article DOI: 10.30574/wjarr.2024.22.3.1835
Publication history: 
Received on 07 May 2024; revised on 25 June 2024; accepted on 27 June 2024
Juvenile nasopharyngeal angiofibroma (JNA) is a benign tumor with locally aggressive behavior, given the significant epistaxis it causes, frequent complications, and therapeutic complexity presented by this condition, diagnosis and treatment should be thorough; it occurs exclusively in adolescent males and accounts for 0.5%-0.05% of all head and neck tumors. This case corresponds to an 18-year-old patient with progressive respiratory difficulty over 2 years, nasal obstruction, and epistaxis. Clinical and imaging studies revealed a diagnosis of JNA at stage IIb according to Radkowski's classification. A Degloving approach was performed, and the tumor was completely removed. One year after resection, no tumor recurrence has been recorded. 
Conclusion: Juvenile nasopharyngeal angiofibroma predominantly affects adolescent males and is primarily characterized by recurrent episodes of epistaxis. Surgical management remains the cornerstone of treatment, with various effective approaches available. The local recurrence rate is low, underscoring the effectiveness of current interventions in most cases.
Angiofibroma; Epistaxis; Nasal Obstruction; Classification; Diagnosis; Approach; Degloving.
Full text article in PDF: 
Share this